Second
Sight Medical Products Inc. (Nasdaq: EYES) announced the first successful
implants of their Argus II Retinal Prosthesis System at two centers in
Italy. The stock price leaped $3.60 to $18.51.
Success in Italy for Second Sight
March 05, 2015 at 11:44 AM EST
